Free Trial

Amicus Therapeutics (FOLD) SEC Filings & 10K Form

Amicus Therapeutics logo
$8.43 -0.16 (-1.86%)
Closing price 03/28/2025 04:00 PM Eastern
Extended Trading
$8.43 0.00 (-0.06%)
As of 03/28/2025 05:42 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Amicus Therapeutics SEC Filings

DateFilerForm TypeView
03/18/2025
4:56 PM
Amicus Therapeutics (Issuer)
Campbell Bradley L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2025
6:27 PM
Amicus Therapeutics (Issuer)
Campbell Bradley L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2025
6:01 AM
Amicus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2025
7:00 PM
Amicus Therapeutics (Subject)
Redmile Group, LLC (Filed by)
Form SCHEDULE 13G/A
02/13/2025
4:14 PM
Amicus Therapeutics (Issuer)
Campbell Bradley L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2025
4:17 PM
Amicus Therapeutics (Issuer)
Clark David Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2025
4:19 PM
Amicus Therapeutics (Issuer)
Castelli Jeff (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2025
4:22 PM
Amicus Therapeutics (Issuer)
Prout Samantha (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2025
4:00 PM
Amicus Therapeutics (Issuer)
Rosenberg Ellen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2025
9:25 AM
Amicus Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SCHEDULE 13G/A
01/13/2025
6:00 AM
Amicus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/06/2025
6:02 PM
Amicus Therapeutics (Issuer)
Harford Simon N.R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
6:03 PM
Amicus Therapeutics (Issuer)
Castelli Jeff (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
6:04 PM
Amicus Therapeutics (Issuer)
Campbell Bradley L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
6:05 PM
Amicus Therapeutics (Issuer)
Clark David Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
6:06 PM
Amicus Therapeutics (Issuer)
Prout Samantha (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
6:06 PM
Amicus Therapeutics (Issuer)
Rosenberg Ellen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2024
5:12 PM
Amicus Therapeutics (Issuer)
Campbell Bradley L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/02/2024
3:43 PM
Amicus Therapeutics (Subject)
Campbell Bradley L (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/14/2024
8:00 PM
Amicus Therapeutics (Subject)
Redmile Group, LLC (Filed by)
Form SC 13G/A
11/14/2024
10:37 AM
Amicus Therapeutics (Subject)
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (Filed by)
Form SC 13G
11/14/2024
8:31 AM
Amicus Therapeutics (Subject)
Avoro Capital Advisors LLC (Filed by)
Form SC 13G/A
11/08/2024
9:52 AM
Amicus Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
11/07/2024
4:49 PM
Amicus Therapeutics (Issuer)
Campbell Bradley L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2024
4:03 PM
Amicus Therapeutics (Subject)
Campbell Bradley L (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/06/2024
6:01 AM
Amicus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/04/2024
5:23 PM
Amicus Therapeutics (Issuer)
Campbell Bradley L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/01/2024
3:49 PM
Amicus Therapeutics (Subject)
Campbell Bradley L (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/17/2024
6:00 AM
Amicus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/07/2024
12:24 PM
Amicus Therapeutics (Subject)
JPMORGAN CHASE & CO (Filed by)
JPMORGAN CHASE & CO (Filed by)
Form SC 13G/A
10/04/2024
3:05 PM
Amicus Therapeutics (Issuer)
Campbell Bradley L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/01/2024
3:35 PM
Amicus Therapeutics (Subject)
Campbell Bradley L (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/03/2024
3:19 PM
Amicus Therapeutics (Subject)
Campbell Bradley L (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/23/2024
4:10 PM
Amicus Therapeutics (Issuer)
Harford Simon N.R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2024
6:01 AM
Amicus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/05/2024
7:10 PM
Amicus Therapeutics (Issuer)
Campbell Bradley L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/09/2024
4:01 PM
Amicus Therapeutics (Issuer)
Campbell Bradley L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2024
3:22 PM
Amicus Therapeutics (Issuer)
Campbell Bradley L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
6:54 PM
Amicus Therapeutics (Issuer)
WHITMAN BURKE W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
6:44 PM
Amicus Therapeutics (Issuer)
RAAB MICHAEL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
6:46 PM
Amicus Therapeutics (Issuer)
SBLENDORIO GLENN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Musk’s real agenda in D.C. (Ad)

In this urgent exposé, you’ll discover… How Elon and Donald Trump are quietly drawing a radical new map of America…

06/07/2024
6:47 PM
Amicus Therapeutics (Issuer)
Kelly Michael Aaron (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
6:49 PM
Amicus Therapeutics (Issuer)
Bleil Lynn Dorsey (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
6:52 PM
Amicus Therapeutics (Issuer)
ROBERTS EIRY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
6:53 PM
Amicus Therapeutics (Issuer)
WHEELER CRAIG A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
6:41 PM
Amicus Therapeutics (Issuer)
MCGLYNN MARGARET G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
3:38 PM
Amicus Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
06/05/2024
3:35 PM
Amicus Therapeutics (Issuer)
Campbell Bradley L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2024
6:00 AM
Amicus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/24/2024
3:31 PM
Amicus Therapeutics (Filer)
Form DEF 14A
04/24/2024
3:32 PM
Amicus Therapeutics (Filer)
Form DEFA14A
04/16/2024
4:42 PM
Amicus Therapeutics (Issuer)
Prout Samantha (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2024
3:27 PM
Amicus Therapeutics (Subject)
Crowley John F (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/03/2024
5:14 PM
Amicus Therapeutics (Issuer)
Campbell Bradley L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools


This page (NASDAQ:FOLD) was last updated on 3/31/2025 by MarketBeat.com Staff
From Our Partners